Key Record Dates
ClinicalTrials.gov Identifier: | NCT05220098 |
---|---|
Brief Title: | First-in-Human Study of TAK-280 in Participants With Unresectable Locally Advanced or Metastatic Cancer |
First Submitted : | January 7, 2022 |
First Submitted that Met QC Criteria : | February 1, 2022 |
First Posted : | February 2, 2022 |
Last Update Submitted that Met QC Criteria : | February 14, 2023 |
Last Update Posted : | February 15, 2023 |